GPS technique developed for evaluating the malignancy of glioma cells
Researchers at Hokkaido University (Sapporo, Japan) have developed a non-invasive method for evaluating the malignancy of brain tumor cells using a Cancer Grade Probing System (GPS). The GPS utilizes a non-destructive, water-soluble, luminescent europium complex to detect and assess brain tumors and their malignancy grades.
While further research is needed to validate the method for human use, the technique could offer a non-invasive way to continuously detect brain tumor activity, informing treatment decisions and enabling monitoring throughout the treatment process.